Visalytics
Visalytics
approved EB-2 (NIW)

Researcher

Clinical Medicine · China · 2023-08-03

Processing Time
6 days
Decision Date
2023-08-03
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue her research in clinical medicine, specifically focusing on advancing diagnostic and therapeutic approaches for gastrointestinal cancer. Her work also involves elucidating molecular and signaling pathways contributing to chronic kidney disease (CKD) and developing strategies to enhance hemodialysis (HD) treatments. The endeavor aims to improve clinical outcomes for patients with complex medical conditions and foster pharmaceutical advancements for targeted disease treatment.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses critical issues in gastrointestinal cancer and chronic kidney disease, which are of significant interest to the U.S. and global health community.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 24 publications, 577 citations, and NIH funding demonstrates her capacity to lead and advance her proposed medical research.

3 Waiver Benefit to the US Met

Given the petitioner's unique skillset and the inherent value of her research in improving clinical outcomes, it is beneficial to waive the labor certification requirement.

Why This Petition Was Approved

The petition was approved based on the petitioner's M.D. and M.S. degrees and her record of 24 peer-reviewed journal publications which garnered 577 citations. She demonstrated her influence in the field by performing 19 manuscript reviews for prestigious journals and receiving funding from the National Institutes of Health (NIH). The case successfully satisfied all three Dhanasar prongs, supported by two expert recommendation letters.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Judging Experience
Original Contributions
Government Alignment

Similar Cases

Research Scientist

Healthcare · India

WeGreened EB-2 (NIW) approved
Massachusetts 20 days 2025-06-05
The petitioner proposes to advance the development of quantitative clinical decision-making tools to enable earlier and more precise interventions for chronic, life-altering diseases. Her work focuses on applying advanced epidemiological and statistical methods to create early detection protocols and personalized treatment strategies. The endeavor aims to improve patient outcomes in high-risk populations while reducing the economic burden of long-term disease management.
View Case

Physician

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
Kentucky 2 days 2023-11-30
The petitioner proposes to develop strategies for early drug toxicity recognition, treatment implementation, and the use of novel therapies for chronic, rare, and evolving kidney diseases. This work aims to improve healthcare outcomes for high-risk patient populations and advance global knowledge in the field of nephrology.
View Case

Epidemiologist

Healthcare · China

WeGreened EB-2 (NIW) rfe approved
Florida 636 days 2025-09-19
The petitioner proposes to advance precision medicine by discovering disease mechanisms for personalized diagnostics and treatments. Her work involves applying multi-omics analysis, bioinformatics, and machine learning to develop predictive models and biomarker-based strategies for cardiometabolic and chronic kidney diseases.
View Case

Others

Healthcare · India

WeGreened EB-2 (NIW) approved
Minnesota 97 days 2025-01-24
The petitioner proposes to advance research focused on developing cutting-edge molecular diagnostic tools, pioneering innovative treatment strategies, and implementing comprehensive patient care models. Specifically, the work aims to study risk factors and transform the early diagnosis and management of gastrointestinal and liver diseases, including cancer.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from China

Case data sourced from publicly available petition decisions and case studies. Decision date: 2023-08-03.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 6 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,814
Success Rate 53.6%
Sustained 2,046
Dismissed 1,672

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in China All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist